OptiNose, Inc. Quarterly Interest Expense in USD from Q3 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
OptiNose, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2016 to Q1 2024.
  • OptiNose, Inc. Interest Expense for the quarter ending March 31, 2024 was $4.97M, a 6.38% increase year-over-year.
  • OptiNose, Inc. Interest Expense for the twelve months ending March 31, 2024 was $19.8M, a 13.7% increase year-over-year.
  • OptiNose, Inc. annual Interest Expense for 2023 was $19.5M, a 15.9% increase from 2022.
  • OptiNose, Inc. annual Interest Expense for 2022 was $16.8M, a 5.45% increase from 2021.
  • OptiNose, Inc. annual Interest Expense for 2021 was $16M, a 22.8% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $19.8M $4.97M +$298K +6.38% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $19.5M $5.09M +$615K +13.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $18.9M $4.94M +$733K +17.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $18.2M $4.82M +$738K +18.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $17.4M $4.67M +$599K +14.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $16.8M $4.48M +$464K +11.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $16.4M $4.21M +$135K +3.32% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $16.2M $4.09M +$74K +1.84% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $16.2M $4.07M +$197K +5.08% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $16M $4.01M +$511K +14.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 $15.5M $4.07M +$722K +21.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $14.7M $4.01M +$719K +21.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $14M $3.88M +$1.01M +35.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $13M $3.5M +$1.03M +41.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-08
Q3 2020 $12M $3.35M +$978K +41.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $11M $3.29M +$904K +37.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $10.1M $2.86M +$475K +19.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $9.62M $2.47M +$100K +4.21% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-03
Q3 2019 $9.52M $2.37M +$11K +0.47% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $9.51M $2.39M +$88K +3.82% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $9.42M $2.39M +$195K +8.89% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $9.23M $2.37M +$2.33M +4846% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 $6.9M $2.36M +$2.36M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $4.54M $2.3M +$2.3M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $2.24M $2.19M +$1.33M +154% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $910K $48K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 $0 -$885K -100% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $862K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q3 2016 $885K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.